Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Jul 2009 11:01

RNS Number : 2364W
Skyepharma PLC
24 July 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SKYEPHARMA PLC

GB00B3BFNB64

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 N/A

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

N/A 

An event changing the breakdown of voting rights

N/A 

Other (please specify):

N/A 

3. Full name of person(s) subject to the notification obligation:

 UBS INVESTMENT BANK

4. Full name of shareholder(s) (if different from 3.):

 UBS AG LONDON BRANCH

5. Date of the transaction and date on which the threshold is crossed or reached:

 22 JULY 2009

6. Date on which issuer notified:

 24 JULY 2009

7. Threshold(s) that is/are crossed or reached:

 6.07%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 GB00B3BFNB64

 1,147,010

 1,147,010

 1,452,702

 1,452,702

 -

 6.07%

 -

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,452,702

 6.07%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

 ESTEBAN FRANK/ALEXA KOENIG

15. Contact telephone number:

 +41 44 239 5476

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKZLBLKDBZBBD
Date   Source Headline
2nd Feb 20067:01 amRNSAppointment of New Chairman
1st Feb 20063:32 pmRNSRule 8.3- (Skyepharma Group)
1st Feb 20063:10 pmRNSRule 8.3- Skyepharma PLC
1st Feb 20062:20 pmRNSRule 8.3- SkyePharma plc
1st Feb 200611:46 amRNSEPT Disclosure
1st Feb 200611:32 amRNSRule 8.3-SkyePharma Plc
31st Jan 20062:54 pmRNSRule 8.3- (Skyepharma Group)
31st Jan 20062:46 pmRNSRule 8.3- Skyepharma PLC
31st Jan 200611:54 amRNSEPT Disclosure
31st Jan 20067:00 amRNSRule 8.3-Skyepharma PLC-Amend
30th Jan 20066:30 pmRNSRule 8.3- (Skyepharma Group)
30th Jan 20066:28 pmRNSRule 8.3- (Skyepharma Group)
30th Jan 200612:32 pmRNSRule 8.3- Skyepharma PLC
30th Jan 200611:18 amRNSRule 8.3-SkyePharma Plc
30th Jan 20067:01 amRNSFurther re call for EGM
27th Jan 20063:08 pmRNSRule 8.3- SkyePharma PLC
27th Jan 20061:19 pmRNSRule 8.3- Skyepharma PLC
27th Jan 200611:39 amRNSEPT Disclosure
26th Jan 20061:39 pmRNSHolding(s) in Company
26th Jan 20061:38 pmRNSRule 8.3- SkyePharma PLC
26th Jan 20061:35 pmRNSRule 8.3- Skyepharma PLC
26th Jan 200611:57 amRNSRule 8.3- Skyepharma Plc
25th Jan 200612:50 pmRNSRule 8.3- Skyepharma Plc
25th Jan 200612:04 pmRNSRule 8.3- SkyePharma PLC
25th Jan 200611:22 amRNSEPT Disclosure
24th Jan 20065:03 pmRNSEPT Disclosure - Amendment
24th Jan 200611:06 amRNSEPT Disclosure
23rd Jan 20064:50 pmRNSHolding(s) in Company
23rd Jan 200611:47 amRNSEPT Disclosure
23rd Jan 200611:45 amRNSEPT Disclosure
19th Jan 200612:13 pmRNSRule 8.3 - Skyepharma PLC
19th Jan 200611:42 amRNSRule 8.3- SkyePharma plc
19th Jan 200611:28 amRNSEPT Disclosure
18th Jan 20061:46 pmRNSRule 8.3 - Skyepharma PLC
18th Jan 200612:52 pmRNSRule 8.3- Skyepharma PLC
18th Jan 200611:17 amRNSEPT Disclosure
17th Jan 20063:09 pmRNSRule 8.3 - Skyepharma PLC
17th Jan 20062:57 pmRNSRule 8.3- Skyepharma PLC
17th Jan 200611:24 amRNSRule 8.3- SkyePharma plc
17th Jan 200611:16 amRNSRule 8.3- Skyepharma Plc
17th Jan 200611:08 amRNSRule 8.3- SkyePharma PLC
17th Jan 200611:02 amRNSEPT Disclosure
16th Jan 200611:01 amRNSNotice of Major Interest
13th Jan 20064:38 pmRNSRule 8.3 - Skyepharma PLC
13th Jan 20063:03 pmRNSRule 8.3- SkyePharma PLC
13th Jan 200612:49 pmRNSNotice of Major Interest
13th Jan 200611:14 amRNSRule 8.3- Skyepharma Plc
13th Jan 200611:03 amRNSEPT Disclosure
13th Jan 200610:29 amRNSRule 8.3- SkyePharma plc
12th Jan 20065:46 pmRNSRule 8.3- SkyePharma PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.